# A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin

> **NCT04124003** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 28 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** rosuvastatin
- **DRUG:** BMS-963272

## Key facts

- **NCT ID:** NCT04124003
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-08
- **Primary completion:** 2020-01-03
- **Final completion:** 2020-01-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2020-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04124003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04124003, "A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04124003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*